1. Home
  2. TMC vs FATE Comparison

TMC vs FATE Comparison

Compare TMC & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMC
  • FATE
  • Stock Information
  • Founded
  • TMC 2011
  • FATE 2007
  • Country
  • TMC Canada
  • FATE United States
  • Employees
  • TMC N/A
  • FATE N/A
  • Industry
  • TMC Metal Mining
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TMC Basic Materials
  • FATE Health Care
  • Exchange
  • TMC Nasdaq
  • FATE Nasdaq
  • Market Cap
  • TMC 2.1B
  • FATE 116.5M
  • IPO Year
  • TMC N/A
  • FATE 2013
  • Fundamental
  • Price
  • TMC $5.49
  • FATE $0.95
  • Analyst Decision
  • TMC Strong Buy
  • FATE Hold
  • Analyst Count
  • TMC 4
  • FATE 6
  • Target Price
  • TMC $6.88
  • FATE $3.30
  • AVG Volume (30 Days)
  • TMC 7.5M
  • FATE 1.3M
  • Earning Date
  • TMC 11-13-2025
  • FATE 11-11-2025
  • Dividend Yield
  • TMC N/A
  • FATE N/A
  • EPS Growth
  • TMC N/A
  • FATE N/A
  • EPS
  • TMC N/A
  • FATE N/A
  • Revenue
  • TMC N/A
  • FATE $8,470,000.00
  • Revenue This Year
  • TMC N/A
  • FATE N/A
  • Revenue Next Year
  • TMC N/A
  • FATE N/A
  • P/E Ratio
  • TMC N/A
  • FATE N/A
  • Revenue Growth
  • TMC N/A
  • FATE N/A
  • 52 Week Low
  • TMC $0.72
  • FATE $0.66
  • 52 Week High
  • TMC $8.63
  • FATE $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TMC 51.42
  • FATE 39.66
  • Support Level
  • TMC $5.04
  • FATE $0.93
  • Resistance Level
  • TMC $5.98
  • FATE $1.08
  • Average True Range (ATR)
  • TMC 0.35
  • FATE 0.07
  • MACD
  • TMC 0.08
  • FATE -0.01
  • Stochastic Oscillator
  • TMC 53.33
  • FATE 8.70

About TMC TMC the metals company Inc.

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: